Should we continue to test soluble thrombomodulin, or other systemic anticoagulants, as a life-saving therapy for sepsis-induced coagulopathy?

Anaesth Crit Care Pain Med. 2019 Oct;38(5):419-421. doi: 10.1016/j.accpm.2019.09.003.

¹ St. Luc Clinical Coordinating Center, Department of Critical Care Medicine, St Luc University Hospital, Université Catholique de Louvain, avenue Hippocrate 10, 1200 Brussels, Belgium. Electronic address: pierre-francois.laterre@uclouvain.be.
² Ocean State Clinical Coordinating Center of Rhode Island Hospital, Providence, RI, USA.
³ St. Luc Clinical Coordinating Center, Department of Critical Care Medicine, St Luc University Hospital, Université Catholique de Louvain, avenue Hippocrate 10, 1200 Brussels, Belgium.
⁴ St. Luc Clinical Coordinating Center, Department of Critical Care Medicine, St Luc University Hospital, Université Catholique de Louvain, avenue Hippocrate 10, 1200 Brussels, Belgium; Department of Critical Care, Clinique St. Pierre, Ottignies, Belgium.
⁵ InsermCIC-1435 & UMR-1092, department of critical care, CHU Dupuytren, 87000, Limoges, France.

No abstract available

Publication types